Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 741 participants.

Also called NCT01164501

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 741 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01164501
  • EudraCT 2009-016179-31
Other papers using this trial's data
  • Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial The lancet. Diabetes & endocrinology, 2014-05 DOI, PubMed 24795251

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, France, Hong Kong SAR China, India, Malaysia, Netherlands, Philippines, Poland, Portugal, Russia, Slovakia, South Africa, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01164501. Randomized; double masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2012-07 (actual). Results posted on 2014-06-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment
Condition
Diabetes Mellitus, Type 2
Condition
Renal Insufficiency
Intervention (Drug)
BI 10773
Intervention (Drug)
Placebo
Intervention (Drug)
Placebo
Intervention (Drug)
BI 10773
Intervention (Drug)
Placebo
Intervention (Drug)
Placebo
Lead sponsor
Boehringer Ingelheim (class: industry)
Collaborator
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct01164501
Content hash
bb7f98a9f3b338b1c378ce4b16a2aa1c113ac1c3b77508114972906a2b944c72